Molecular and cellular factors determining the functional pleiotropy of cytokines

被引:13
|
作者
McFarlane, Alison [1 ]
Pohler, Elizabeth [1 ]
Moraga, Ignacio [1 ]
机构
[1] Univ Dundee, Sch Life Sci, Div Cell Signalling & Immunol, Dundee DD1 5EH, Scotland
基金
英国惠康基金; 欧洲研究理事会;
关键词
cytokine signalling; endosomes signalling; JAK; STAT signalling pathway; pleiotropy; protein engineering; I INTERFERON-RECEPTOR; LEUKEMIA INHIBITORY FACTOR; ONCOSTATIN-M-RECEPTOR; HUMAN GROWTH-HORMONE; COMMON GAMMA-CHAIN; ERYTHROPOIETIN RECEPTOR; CRYSTAL-STRUCTURE; ALPHA-RECEPTOR; SIGNAL TRANSDUCER; COMPLEX REVEALS;
D O I
10.1111/febs.16420
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cytokines are soluble factors vital for mammalian physiology. Cytokines elicit highly pleiotropic activities, characterized by their ability to induce a wide spectrum of functional responses in a diverse range of cell subsets, which makes their study very challenging. Cytokines activate signalling via receptor dimerization/oligomerization, triggering activation of the JAK (Janus kinase)/STAT (signal transducer and activator of transcription) signalling pathway. Given the strong crosstalk and shared usage of key components of cytokine signalling pathways, a long-standing question in the field pertains to how functional diversity is achieved by cytokines. Here, we discuss how biophysical - for example, ligand-receptor binding affinity and topology - and cellular - for example, receptor, JAK and STAT protein levels, endosomal compartment - parameters contribute to the modulation and diversification of cytokine responses. We review how these parameters ultimately converge into a common mechanism to fine-tune cytokine signalling that involves the control of the number of Tyr residues phosphorylated in the receptor intracellular domain upon cytokine stimulation. This results in different kinetics of STAT activation, and induction of specific gene expression programs, ensuring the generation of functional diversity by cytokines using a limited set of signalling intermediaries. We describe how these first principles of cytokine signalling have been exploited using protein engineering to design cytokine variants with more specific and less toxic responses for immunotherapy.
引用
收藏
页码:2525 / 2552
页数:28
相关论文
共 50 条
  • [21] Cellular biology of myomas: Interaction of sex steroids with cytokines and growth factors
    Sozen, I
    Arici, A
    OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2006, 33 (01) : 41 - +
  • [22] Metabolic and cellular factors determining the therapeutic effect of dimethyl fumarate
    Kosinska, J.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2023, 396 : S65 - S66
  • [23] Cytokine pleiotropy and redundancy -: gp130 cytokines in human implantation
    Sánchez-Cuenca, L
    Martín, JC
    Pellicer, A
    Simón, C
    IMMUNOLOGY TODAY, 1999, 20 (02): : 57 - 59
  • [24] More and more pleiotropy within the IL-6 family of cytokines
    Rose-John, Stefan
    Jones, Simon A.
    FEBS JOURNAL, 2025, 292 (03) : 519 - 522
  • [25] Evaluation of factors determining functional remission in patients with schizophrenia
    Sarma, Navanita
    Ghosh, Prosenjit
    INDIAN JOURNAL OF PSYCHIATRY, 2024, 66 : S40 - S40
  • [26] Cytokines as cellular communicators
    Debets, R
    Savelkoul, HFJ
    MEDIATORS OF INFLAMMATION, 1996, 5 (06) : 417 - 423
  • [27] Cellular and Molecular Factors Influencing Tendon Repair
    Durgam, Sushmitha
    Stewart, Matthew
    TISSUE ENGINEERING PART B-REVIEWS, 2017, 23 (04) : 307 - 317
  • [28] Growth factors and cytokines: Function and molecular regulation in pituitary adenomas
    Renner, U
    Paez-Pereda, M
    Arzt, E
    Stalla, GK
    MOLECULAR PATHOLOGY OF THE PITUITARY, 2004, 32 : 96 - 109
  • [29] Incorporating antagonistic pleiotropy into models for molecular replicators
    Qu, Tianjiao
    Calabrese, Peter
    Singhavi, Pratik
    Tower, John
    BIOSYSTEMS, 2021, 201
  • [30] Determining the molecular factors that control apoptotic cell disassembly
    Tixeira, R.
    Nedeva, C.
    Atkin-Smith, G.
    Phan, K.
    Puthalakath, H.
    Herold, M.
    Hulett, M.
    Poon, I
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 722 - 722